ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

2025 Urology Care Foundation Research Scholar Awardees Announced

BALTIMORE, Aug. 07, 2025 (GLOBE NEWSWIRE) -- The American Urological Association (AUA) and the Urology Care Foundation, the official foundation of the AUA, are pleased to recognize 12 researchers as recipients of the 2025 Urology Care Foundation Research Scholar Awards. Research Scholar Awards support future research leaders and ensure they receive the necessary training and guidance for a successful research career.

These awards provide $40,000 annually for one or two-year mentored research training for clinical and postdoctoral fellows or early-career faculty. The program has invested over $30 million to support over 675 Research Scholars, most of whom have remained in committed research career tracks and now serve as leaders in urologic research and clinical practice.

“The Urology Care Foundation is proud to support this exceptional group of Research Scholar Awardees. Their innovative projects span a wide spectrum of urologic investigation,” said Harris M. Nagler, MD, FACS, president of the Urology Care Foundation. “By investing in these rising leaders and their innovative research, we’re advancing the future of urologic care so that we may ultimately improve urologic care for all patients.”

Congratulations to the 2025 awardees:

AUA New England Section Wyland F. Leadbetter, MD Award: Andrea Sartori, PhD, will receive support for a one-year research project titled “Unveiling the Spinal Neurons Central to Human Lower Urinary Tract Regulation.”

AUA New York Section E. Darracott Vaughan, Jr., MD Award: Ao Zhang, MD, PhD, will receive support for a one-year research project titled “Characterization of Heterogenous Response to Antibody-Drug Conjugates in Bladder Cancer With Variant Histology.”

AUA Southeastern Section: Apoorv Dhir, MD, will receive support for a one-year research project titled “Development of a Universal Communication Framework to Improve Shared Decision-Making for Small Renal Masses.”

AUA Southeastern Section: Renzo DiNatale will receive support for a one-year research project titled “Clinical Risk Stratification and Tumor Heterogeneity Assessment in Upper Tract Urothelial Carcinoma.”

AUA South Central Section: Lin Lin, MD, PhD, will receive support for a one-year research project titled “Functional Mitochondrial Complex I Predicts Clear Cell Renal Cell Carcinoma Metastasis.” 

AUA Western Section: Lauren Newman, PhD, will receive support for a two-year research project titled “EV Liquid Biopsy for Molecular Phenotyping in Prostate Cancer.”

Endourological Society Award: Nabeel Shakir, MD, will receive support for a two-year research project titled “A Multiphase Optimization Strategy to Reduce Delays in Management of Chronic Nephrostomy Tubes.”

Endourological Society Joseph Segura, MD Scholarship in Endourology and Stone Management: Juan Serna, MD, will receive support for a one-year research project titled “Is There a Benefit to Selective Medical Therapy for Calcium Oxalate Stone Prevention Vs an Empiric Approach? A Randomized Control Trial.” 

Endourological Society Raju Thomas, MD Award: Connor Forbes, MD, will receive support for a two-year research project titled “Characterizing Hormonal Pathways in Benign Prostate Hyperplasia (BPH).”

Indian American Urological Association Sakti Das, MD Award: Nixon Raj, PhD, will receive support for a two-year research project titled “Investigating Dysregulation of Smooth Muscle Contractile Machinery in Detrusor Underactivity States Like Prune Belly Syndrome.”

Society of Urologic Oncology Award: Aisha Siebert, MD, PhD, MPH, will receive support for a two-year research project titled “Genetic Markers of Gonadal Malignancy Risk in XY Differences of Sex Development (DSD).” 

Society of Urologic Oncology Award: Jianhua Xiong, PhD, will receive support for a two-year research project titled “Lipid Metabolic Reprogramming in Castration-Resistant Prostate Cancer: Role of FASN And CPT1A In Tumor Progression and Resistance.”

"Each year, I’m inspired by the depth and diversity of research our scholars pursue,” said Henry Lai, MD, chair of the AUA's Research Council. “These awardees are tackling some of the most pressing questions in urology, and through the support of the Research Scholar Awards, we’re helping shape the next generation of leaders who will drive innovation and elevate our field.”

To learn more about the Urology Care Foundation Research Scholar Awards visit: https://www.auanet.org/research-and-data/research-awards/aua-funding/research-scholar-awards

About the American Urological Association: Founded in 1902 and headquartered near Baltimore, Maryland, the American Urological Association is a leading advocate for the specialty of urology and has nearly 24,000 members throughout the world. The AUA is a premier urologic association, providing invaluable support to the urologic community as it pursues its mission of fostering the highest standards of urologic care through education, research and the formulation of health policy.

About the Urology Care Foundation: The Urology Care Foundation is the world's leading nonprofit urological health foundation, and the official foundation of the American Urological Association. Collaborating with physicians, researchers, patients and the public through philanthropic efforts, the Foundation supports the improvement of urological care globally by funding research, clinical education, patient education and humanitarian programs. To learn more about the Urology Care Foundation and its programs visit: www.urologyhealth.org.

Attachment


Corey Del Bianco
Urology Care Foundation
443-689-4033
cdelbianco@auanet.org
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.